$6.24
1.41% today
Nasdaq, Aug 25, 05:49 pm CET
ISIN
US53216B1044
Symbol
LFMD

LifeMD Stock price

$6.33
-4.03 38.90% 1M
+0.61 10.66% 6M
+1.38 27.88% YTD
+1.27 25.10% 1Y
+3.75 145.35% 3Y
+1.68 36.13% 5Y
+5.78 1,051.96% 10Y
+5.93 1,462.96% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.04 0.64%
ISIN
US53216B1044
Symbol
LFMD

Key metrics

Basic
Market capitalization
$300.2m
Enterprise Value
$279.4m
Net debt
positive
Cash
$36.2m
Shares outstanding
45.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.2 | 1.2
EV/Sales
1.1 | 1.1
EV/FCF
41.7
P/B
negative
Financial Health
Equity Ratio
-7.6%
Return on Equity
400.8%
ROCE
-20.3%
ROIC
-
Debt/Equity
-8.7
Financials (TTM | estimate)
Revenue
$245.6m | $258.1m
EBITDA
$8.6m | $33.2m
EBIT
$-2.0m | $11.0m
Net Income
$-9.0m | $-3.3m
Free Cash Flow
$6.7m
Growth (TTM | estimate)
Revenue
37.7% | 21.5%
EBITDA
176.6% | 599.8%
EBIT
89.4% | 168.2%
Net Income
66.1% | 85.0%
Free Cash Flow
1.7%
Margin (TTM | estimate)
Gross
87.6%
EBITDA
3.5% | 12.9%
EBIT
-0.8%
Net
-3.7% | -1.3%
Free Cash Flow
2.7%
More
EPS
$-0.2
FCF per Share
$0.1
Short interest
11.9%
Employees
306
Rev per Employee
$690.0k
Show more

Is LifeMD a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

LifeMD Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a LifeMD forecast:

13x Buy
87%
2x Hold
13%

Analyst Opinions

15 Analysts have issued a LifeMD forecast:

Buy
87%
Hold
13%

Financial data from LifeMD

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
246 246
38% 38%
100%
- Direct Costs 31 31
54% 54%
12%
215 215
36% 36%
88%
- Selling and Administrative Expenses 197 197
21% 21%
80%
- Research and Development Expense 10 10
31% 31%
4%
8.55 8.55
177% 177%
3%
- Depreciation and Amortization 11 11
31% 31%
4%
EBIT (Operating Income) EBIT -2.03 -2.03
89% 89%
-1%
Net Profit -9.03 -9.03
66% 66%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about LifeMD directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeMD Stock News

Neutral
GlobeNewsWire
about 24 hours ago
NEW YORK, Aug. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public.
Neutral
GlobeNewsWire
4 days ago
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public.
Neutral
Seeking Alpha
6 days ago
LifeMD saw year-over-year revenue growth for its second quarter slow markedly from the comparable figure in the first quarter. Gross profit margins dipped 200 basis points, versus its year-ago period, as revenue guidance for 2025 was revised down. LFMD is now trading at a 1.2x price-to-sales multiple, but faces a risk from a further growth slowdown.
More LifeMD News

Company Profile

LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.

Head office United States
CEO Justin Schreiber
Employees 306
Founded 1987
Website lifemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today